These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33536906)

  • 21. Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
    Li CY; Yin JG; Zhang J; Wang XX; Xu MJ; Liu F; Zou JD; Ju WZ
    J Ethnopharmacol; 2015 Mar; 162():225-30. PubMed ID: 25576896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-anaphylactoid effects of hydroxysafflor yellow A on the suppression of mast cell Ca
    Liu R; Zhao T; Che D; Cao J; Wang J; Lv Y; Ma P; Ding Y; Wang N; Wang X; Wang N; Wang J; Gao Z; Zhang T
    Phytomedicine; 2018 Sep; 48():43-50. PubMed ID: 30195879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by (1)H NMR-Based Metabonomics and the NF-κB Pathway.
    Liu Y; Lian Z; Zhu H; Wang Y; Yu S; Chen T; Qu J; Li J; Ma S; Chen X
    Evid Based Complement Alternat Med; 2013; 2013():147362. PubMed ID: 23710208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis
    Fangma Y; Zhou H; Shao C; Yu L; Yang J; Wan H; He Y
    Front Pharmacol; 2021; 12():739864. PubMed ID: 34658877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
    Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
    Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxysafflor Yellow A Blocks HIF-1
    Li Y; Liu XT; Zhang PL; Li YC; Sun MR; Wang YT; Wang SP; Yang H; Liu BL; Wang M; Gao W; Li P
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hydroxysafflor yellow A on rats with collagen-induced arthritis.
    Li DW; Wang XT; Mu BC; Dou DQ; Kang TG
    Biochem Biophys Res Commun; 2021 Sep; 570():26-34. PubMed ID: 34271433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of hydroxysafflor yellow A on renal ischemia‑-reperfusion injury by targeting the Akt‑Nrf2 axis in mice.
    Wang Y; Han K; Li Z; Tang X; Wang C; Zhao Y; Zhang H; Geng Z; Kong J; Luan X; Xiong Y
    Exp Ther Med; 2022 Dec; 24(6):741. PubMed ID: 36478883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.
    Wang X; Ma Z; Fu Z; Gao S; Yang L; Jin Y; Sun H; Wang C; Fan W; Chen L; Zheng QY; Bi G; Ma CL
    ASN Neuro; 2016; 8(2):. PubMed ID: 27067428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase.
    Xu Y; Lee J; Park YD; Yang JM; Zheng J; Zhang Q
    J Biomol Struct Dyn; 2018 Mar; 36(4):830-840. PubMed ID: 28264629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
    Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
    J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
    Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
    Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic neuroprotective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats.
    Xu H; Liu W; Liu T; Su N; Guo C; Feng X; Dou F; Ding Y; Shi L; Wen A
    Oncotarget; 2017 Dec; 8(70):115434-115443. PubMed ID: 29383171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury
    Ye J; Lu S; Wang M; Ge W; Liu H; Qi Y; Fu J; Zhang Q; Zhang B; Sun G; Sun X
    Front Pharmacol; 2020; 11():1170. PubMed ID: 32848777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice.
    Yao R; Cao Y; Jiang R; Zhang X; Li F; Wang S
    Biomed Chromatogr; 2021 Oct; 35(10):e5173. PubMed ID: 33982286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.
    Tian Y; Yang ZF; Li Y; Qiao Y; Yang J; Jia YY; Wen AD
    J Ethnopharmacol; 2010 May; 129(1):1-4. PubMed ID: 20206677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.
    Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H
    Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxysafflor Yellow A Suppresses Platelet Activating Factor-Induced Activation of Human Small Airway Epithelial Cells.
    Guo X; Zheng M; Pan R; Zang B; Jin M
    Front Pharmacol; 2018; 9():859. PubMed ID: 30123133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.
    Lv LZ; Tong CQ; Lv Q; Tang XJ; Li LM; Fang QX; Yu J; Han M; Gao JQ
    Int J Nanomedicine; 2012; 7():4099-107. PubMed ID: 22888246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
    Wang J; Zhang Q; Mei X; Zhang X
    Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.